Transfusing umbilical-cord derived stem cells to patients with severe COVID-19 has significant benefit, US researchers have reported.
The mesenchymal stem cells appear to safely halt the cytokine storm, characteristic of Covid-19, speeding recover...
3 years ago
There is no benefit to raising the haemoglobin threshold for blood transfusions for extremely low birthweight babies, according to a new analysis.
Babies who are born before 29 weeks of pregnancy or weigh less than 1,000 grams have a raised risk o...
3 years ago
